Lukic, Ruzica, et al. “Increased Systemic SST2 in Patients With End Stage Renal Disease Contributes to Milder Liver Damage During HCV Infection”. The Journal of Infection in Developing Countries, vol. 14, no. 05, May 2020, pp. 519-26, doi:10.3855/jidc.11741.